Scientific publications

NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases

Feb 1, 2008 | Magazine: Clinical Science

San José G, Fortuño A, Beloqui O, Díez J, Zalba G.
Division of Cardiovascular Sciences, Centre for Applied Medical Research, School of Medicine, University of Navarra, 31008 Pamplona, Spain

Oxidative stress plays a key role in the pathophysiology of several major cardiovascular diseases, including atherosclerosis, hypertension, heart failure, stroke and diabetes. ROS (reactive oxygen species) affect multiple tissues either directly or through NO depletion.

ROS induce cardiovascular dysfunction by modulating cell contraction/dilation, migration, growth/apoptosis and extracellular matrix protein turnover, which contribute to vascular and cardiac remodelling. Of the several sources of ROS within the cardiovascular system, a family of multisubunit NADPH oxidases appears to be a predominant contributor of superoxide anion. Recent findings suggest a significant role of the genetic background in NADPH oxidase regulation. Common genetic polymorphisms within the promoter and exonic sequences of CYBA, the gene that encodes the p22(phox) subunit of NADPH oxidase, have been characterized in the context of cardiovascular diseases.

This review aims to present the current state of research into these polymorphisms in their relationship to cardiovascular diseases.

CITATION  Clin Sci (Lond). 2008 Feb;114(3):173-82

Our authors

Navarre headquarters
Madrid headquarters